Pronova BioPharma ASA: Mandatory Notification of Trade
(Thomson Reuters ONE) -
30 May 2012, Lysaker, Norway: Primary insider, CEO in Pronova BioPharma ASA,
Morten Jurs, has bought 10 000 shares in the company today.
The shares were bought at an average share price of NOK 10.00 and are held by
Jurs AS, which is owned 100 percent by Morten Jurs.
Total number of shares held by Mr Jurs after the purchase is 529 375 shares held
by Jurs AS.
This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Pronova BioPharma ASA via Thomson Reuters ONE
[HUG#1615866]
Unternehmensinformation / Kurzprofil:
Datum: 30.05.2012 - 09:40 Uhr
Sprache: Deutsch
News-ID 151077
Anzahl Zeichen: 1110
contact information:
Town:
Lysaker
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 162 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Pronova BioPharma ASA: Mandatory Notification of Trade"
steht unter der journalistisch-redaktionellen Verantwortung von
Pronova BioPharma ASA (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
